Drug Trial Radar · NCT06081920
A Study of IBI363 in Subjects With Advanced Melanoma
Last checked: Nov 19, 2026Latest source record: Jul 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
180
Planned (sponsor's estimate)
Start
Oct 19, 2023
Primary completion
Oct 19, 2028
Study completion Oct 19, 2028
Sponsor
- Lead sponsor
- Innovent Biologics (Suzhou) Co. Ltd.Industry
- Sponsor type
- Industry
- First posted
- Oct 13, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-lable, multicenter Phase II study to evaluate the safety, tolerability, and efficacy of IBI363 in advanced melanoma patients
Conditions
- Melanoma
Interventions
IBI363Biological
IBI363 monotherapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- AE(Adverse event)Time frame: 2 years
- ORR(Objective response rate)Time frame: 2 years
- DoR(duration of response)Time frame: 2 years
- PFS (progression free survival)Time frame: 2 years
- DCR (disease control rate)Time frame: 2 years
- TTR (time to response)Time frame: 2 years
- TTP (time to progression)Time frame: 2 years
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Beijing Cancer Hospital
Beijing, Beijing Municipality, China · Recruiting
Peking University Cancer Hospital & Institute, Beijing, China,
Beijing, Beijing Municipality, China · Recruiting
Fujian Cancer Hospital
Fuzhou, Fujian, China · Recruiting
The Third people's hospital of Zhengzhou
Zhengzhou, Henan, China · Recruiting
Hunan Cancer Hospital
Changsha, Hunan, China · Recruiting
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China · Recruiting
The first affiliated hospital of Nanchang university
Nanchang, Jiangxi, China · Recruiting
Jilin Cancer Hospital
Changchun, Jilin, China · Recruiting
The first hospital of Jilin University
Changchun, Jilin, China · Recruiting
Qilu Hospital of Shandong university
Jinan, Shandong, China · Recruiting
Shanxi Bethune Hospital
Taiyuan, Shanxi, China · Recruiting
Yunan Cancer Hospital
Kunming, Yunan, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.